Furthermore, AFP has also demonstrated improved clinical performance in patients with hepatitis C virus (HCV) and preserved liver function as a result of antiviral therapy35, suggesting that AFP-L3 may no longer meaningfully contribute to the detection of HCC, either as a standalone biomarker or as part of the GALAD diagnostic algorithm. Here, AFP is linked to hepatocellular carcinoma.